Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001341004-16-001401
Filing Date
2016-05-10
Accepted
2016-05-10 16:36:05
Documents
1
Period of Report
2016-03-31
Effectiveness Date
2016-05-10

Document Format Files

Seq Description Document Type Size
1 NT 10-Q nt10-q.htm NT 10-Q 48275
  Complete submission text file 0001341004-16-001401.txt   49548
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 161636287
SIC: 2834 Pharmaceutical Preparations